You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ivosidenib

Showing 26 - 33 of 33
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed or Refractory Acute Myeloid Leukemia (AML), Untreated AML, Other IDH1-mutated Positive Hematologic Malignancies Trial

Recruiting
  • Relapsed or Refractory Acute Myeloid Leukemia (AML)
  • +3 more
  • Birmingham, Alabama
  • +26 more
Sep 12, 2022

Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute Trial in Canada, United States (Iomab-B, Conventional

Active, not recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Gilbert, Arizona
  • +23 more
Feb 22, 2022

Acute Myeloid Leukemia, Relapsed Adult AML, Relapsed Pediatric AML Trial (ivosidenib (AG-120))

Approved for marketing
  • Acute Myeloid Leukemia
  • +2 more
  • ivosidenib (AG-120)
  • (no location specified)
Jul 20, 2018

Hepatic Impairment Trial in Lakewood, Minneapolis (AG-120 (Ivosidenib))

Completed
  • Hepatic Impairment
  • AG-120 (Ivosidenib)
  • Lakewood, Colorado
  • +1 more
Apr 26, 2018

Healthy Trial in Cypress (ivosidenib (AG-120))

Completed
  • Healthy
  • ivosidenib (AG-120)
  • Cypress, California
    West Coast Clinical Trial (WCCT)
Jan 9, 2018

Acute Lymphoblastic Leukemia Recurrent, Acute Lymphoblastic Leukemia, in Relapse, Acute Myeloid Leukemia, in Relapse Trial in

Unknown status
  • Acute Lymphoblastic Leukemia Recurrent
  • +4 more
  • INA03 administration
  • Marseille, Bouches-du Rhône, France
  • +1 more
Feb 4, 2020

Healthy Trial in Madison (AG120)

Completed
  • Healthy
  • Madison, Wisconsin
    Research Site
Nov 28, 2016

Healthy Volunteers Trial in Madison ([14C]-AG-120)

Completed
  • Healthy Volunteers
  • Madison, Wisconsin
    Research Site
Dec 11, 2015